| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA996: Linzagolix for treating moderate to severe symptoms of uterine fibroids |
|
Medicine details |
|
| Medicine name | linzagolix (Yselty®) |
| Formulation | 100 mg, 200 mg film-coated tablets |
| Reference number | 4751 |
| Indication | Linzagolix for treating moderate to severe symptoms of uterine fibroids |
| Company | Theramex Ireland Limited |
| BNF chapter | Obstetrics, gynaecology & urinary tract disorders |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 14/06/2024 |
| NICE guidance | TA996: Linzagolix for treating moderate to severe symptoms of uterine fibroids |